Tag
Orchid Pharma Limited
4 articles
Orchid Pharma Q1 FY27 Earnings Call Recording Available
Orchid Pharma uploaded audio recording of Q1 FY27 earnings call held August 21, 2026.
Call discussed unaudited limited reviewed financial results for quarter ended June 30, 2026.
Company confirmed no
Orchid Pharma Q1 Revenue Up 16% YoY
Orchid Pharma submitted an investor presentation for Q1 FY27, reporting standalone revenue of ₹304 Cr, a 16% YoY increase.
EBITDA surged 178% to ₹25 Cr, while PAT was ₹12 Cr, a significant improvement
Orchid Pharma Q1 FY27 Results Analyst Call
Orchid Pharma schedules Q1 FY27 results analyst call for August 21, 2026, hosted by Systematix Institutional Equities.
Management participants include MD Manish Dhanuka, Whole Time Director Mridul Dha
Orchid Pharma Posts Revised FY26 Results Post-Merger
Orchid Pharma revised its audited standalone and consolidated FY26 financial results to incorporate the NCLT-sanctioned merger with Dhanuka Laboratories, effective from April 1, 2024.
Standalone net p